BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36460206)

  • 1. Syndecan-4 regulates the HER2-positive breast cancer cell proliferation cells via CK19/AKT signalling.
    Pham SH; Vuorinen SI; Arif KT; Griffiths LR; Okolicsanyi RK; Haupt LM
    Biochimie; 2023 Apr; 207():49-61. PubMed ID: 36460206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syndecan-1 and -4 influence Wnt signaling and cell migration in human breast cancers.
    Pham SH; Pratt K; Okolicsanyi RK; Oikari LE; Yu C; Peall IW; Arif KT; Chalmers TA; Gyimesi M; Griffiths LR; Haupt LM
    Biochimie; 2022 Jul; 198():60-75. PubMed ID: 35183674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SDC4-rs1981429 and ATM-rs228590 may provide early biomarkers of breast cancer risk.
    Vuorinen SI; Okolicsanyi RK; Gyimesi M; Meyjes-Brown J; Saini D; Pham SH; Griffiths LR; Haupt LM
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):4563-4578. PubMed ID: 36152082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicity.
    Okolicsanyi RK; van Wijnen AJ; Cool SM; Stein GS; Griffiths LR; Haupt LM
    J Cell Biochem; 2014 May; 115(5):967-76. PubMed ID: 24357546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localisation of specific heparan sulfate proteoglycans during the proliferative phase of brain development.
    Ford-Perriss M; Turner K; Guimond S; Apedaile A; Haubeck HD; Turnbull J; Murphy M
    Dev Dyn; 2003 Jun; 227(2):170-84. PubMed ID: 12761845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perturbation of the heparin/heparin-sulfate interactome of human breast cancer cells modulates pro-tumourigenic effects associated with PI3K/Akt and MAPK/ERK signalling.
    Chen Y; Scully M; Dawson G; Goodwin C; Xia M; Lu X; Kakkar A
    Thromb Haemost; 2013 Jun; 109(6):1148-57. PubMed ID: 23571852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparan sulfate mediates trastuzumab effect in breast cancer cells.
    Suarez ER; Paredes-Gamero EJ; Del Giglio A; Tersariol IL; Nader HB; Pinhal MA
    BMC Cancer; 2013 Oct; 13():444. PubMed ID: 24083474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell surface heparan sulfate proteoglycans control adhesion and invasion of breast carcinoma cells.
    Lim HC; Multhaupt HA; Couchman JR
    Mol Cancer; 2015 Jan; 14(1):15. PubMed ID: 25623282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data on 2D culture characterisation of potential markers in human HER2-positive breast cancer cell lines.
    Pham SH; Griffiths LR; Okolicsanyi RK; Haupt LM
    Data Brief; 2023 Feb; 46():108880. PubMed ID: 36687151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation.
    Fisher MC; Li Y; Seghatoleslami MR; Dealy CN; Kosher RA
    Matrix Biol; 2006 Jan; 25(1):27-39. PubMed ID: 16226436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of heparan sulfate proteoglycans SDC1 and SDC4 polymorphisms with breast cancer in an Australian Caucasian population.
    Okolicsanyi RK; Buffiere A; Jacinto JM; Chacon-Cortes D; Chambers SK; Youl PH; Haupt LM; Griffiths LR
    Tumour Biol; 2015 Mar; 36(3):1731-8. PubMed ID: 25361632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell surface heparan sulfate proteoglycans control the response of renal interstitial fibroblasts to fibroblast growth factor-2.
    Clayton A; Thomas J; Thomas GJ; Davies M; Steadman R
    Kidney Int; 2001 Jun; 59(6):2084-94. PubMed ID: 11380810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses.
    Shafti-Keramat S; Handisurya A; Kriehuber E; Meneguzzi G; Slupetzky K; Kirnbauer R
    J Virol; 2003 Dec; 77(24):13125-35. PubMed ID: 14645569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of natural cytotoxicity receptors by heparan sulfate proteoglycans in -cis: A lesson from NKp44.
    Brusilovsky M; Radinsky O; Cohen L; Yossef R; Shemesh A; Braiman A; Mandelboim O; Campbell KS; Porgador A
    Eur J Immunol; 2015 Apr; 45(4):1180-91. PubMed ID: 25546090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA-140-3p modulates invasiveness, motility, and extracellular matrix adhesion of breast cancer cells by targeting syndecan-4.
    Onyeisi JOS; Greve B; Espinoza-Sánchez NA; Kiesel L; Lopes CC; Götte M
    J Cell Biochem; 2021 Oct; 122(10):1491-1505. PubMed ID: 34180077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of ureteric bud branching morphogenesis by sulfated proteoglycans in the developing kidney.
    Steer DL; Shah MM; Bush KT; Stuart RO; Sampogna RV; Meyer TN; Schwesinger C; Bai X; Esko JD; Nigam SK
    Dev Biol; 2004 Aug; 272(2):310-27. PubMed ID: 15282150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer.
    Wang J; Ji H; Niu X; Yin L; Wang Y; Gu Y; Li D; Zhang H; Lu M; Zhang F; Zhang Q
    Dis Markers; 2020; 2020():6103542. PubMed ID: 32377271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D culture of Her2+ breast cancer cells promotes AKT to MAPK switching and a loss of therapeutic response.
    Gangadhara S; Smith C; Barrett-Lee P; Hiscox S
    BMC Cancer; 2016 Jun; 16():345. PubMed ID: 27251376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming trastuzumab resistance in HER2-overexpressing breast cancer cells by using a novel celecoxib-derived phosphoinositide-dependent kinase-1 inhibitor.
    Tseng PH; Wang YC; Weng SC; Weng JR; Chen CS; Brueggemeier RW; Shapiro CL; Chen CY; Dunn SE; Pollak M; Chen CS
    Mol Pharmacol; 2006 Nov; 70(5):1534-41. PubMed ID: 16887935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparan sulfate proteoglycans are receptors for the cell-surface trafficking and biological activity of transglutaminase-2.
    Scarpellini A; Germack R; Lortat-Jacob H; Muramatsu T; Billett E; Johnson T; Verderio EA
    J Biol Chem; 2009 Jul; 284(27):18411-23. PubMed ID: 19398782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.